Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1305, 2001-01, pp. : 15-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tenecteplase plus enoxaparin sodium emerged as the best option
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Access to resources
Recommend
Growth hormone debate reaches new heights
Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. :
ASSENT 3 PLUS: prehospital thrombolytics beneficial
Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. :
Enoxaparin sodium recommended as antithrombotic of choice in acute MI
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :
Enoxaparin sodium reduces poststenting MI rates
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :